Revance Therapeutics Inc (RVNC)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1222 DEMONBREUN STREET NASHVILLE, TN 37203

Revance Therapeutics, Inc produces biopharmaceutical products. The company develops drug delivery and treatments for dermatology and aesthetic medicine. Revance Therapeutics serves patients and doctors throughout the United States.

Data as of 2021-04-17 10:45:09 -0400
Market Cap1.943 Billion Shares Outstanding71.383 Million Avg 30-day Volume403.92 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-6.82 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.44527 52-week High/Low34.62 / 15.52 Next Earnings Date2021-05-06 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from RVNC instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 2 (0.12%) 2 (0.12%) 0.0%
Funds Holding: 144 152 -5.26% 41 (2.46%) 47 (2.93%) -12.77%
13F shares: 52.649 Million 49.47 Million 6.43% 22.67 Million 23.954 Million -5.36%
% Ownership 79.1135 74.3357 6.43% 34.0647 35.9947 -5.36%
New Positions: 24 22 9.09% 8 3 166.67%
Increased Positions 49 64 -23.44% 9 23 -60.87%
Closed Positions 27 13 107.69% 12 7 71.43%
Reduced Positions 45 38 18.42% 18 16 12.5%
Total Calls 209.626 Thousand 282.324 Thousand -25.75% 83 Thousand 88.6 Thousand -6.32%
Total Puts 452.734 Thousand 413.536 Thousand 9.48% 379.4 Thousand 316 Thousand 20.06%
PUT/CALL Ratio 2.16 1.46 47.95% 4.57 3.57 28.01%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RVNC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RVNC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

33.1 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SJUTS DUSTIN S CHIEF COMMERCIAL OFFICER

  • Officer
65,098 2021-04-15 7

RANKIN AUBREY PRESIDENT, INNOVATION & TECH

  • Officer
  • Director
665,403 2021-04-05 11

JOSHI ABHAY COO, PRESIDENT, R&D

  • Officer
128,368 2021-03-15 4

MOXIE DWIGHT SVP, GC & SECRETARY

  • Officer
49,479 2021-03-15 3

WARE OLIVIA C

  • Director
17,569 2021-03-08 2

KOLAJA CAREY OCONNOR

  • Director
0 2021-03-01 2

SCHILKE TOBIN CFO

  • Officer
68,762 2021-02-15 6

FOLEY MARK J CEO & PRESIDENT

  • Officer
  • Director
881,192 2021-02-02 3

BYRNES ROBERT F

  • Director
30,165 2020-05-14 1

VICKERS PHILIP J.

  • Director
19,650 2020-05-14 1

GARDNER PHYLLIS

  • Director
16,500 2020-05-14 1

RUSSELL ANGUS C.

  • Director
16,500 2020-05-14 1

GANGOLLI JULIAN S

  • Director
16,500 2020-05-14 1

BERAUD JILL

  • Director
15,000 2020-05-14 1

NOLET CHRIS

  • Director
15,000 2020-05-14 1

MCDOWELL CARYN GORDON SVP, GC & SECRETARY

  • Officer
23,453 2020-02-15 0

BROWNE L DANIEL CEO AND PRESIDENT

  • Officer
  • Director
152,602 2019-06-28 0

ALLOUCHE CYRIL PRINCIPAL ACCOUNTING OFFICER

  • Officer
6,400 2019-03-15 0

ZAVODNICK TODD ERIK CCO & PRESIDENT,

  • Officer
  • AESTHETICS & THERAPUTICS
96,407 2018-10-15 0

SILVERNAIL LAUREN P CFO & CBO

  • Officer
65,497 2018-05-22 0

EASTMAN RONALD W

  • Director
  • 10% Owner
4,137,962 2017-05-11 0

RUEGG CURTIS EVP, TECHNICAL OPERATIONS

  • Officer
23,944 2016-06-13 0

GLASHEEN JAMES WALTER

  • Director
0 2016-05-05 0

PRYGOCKI MARK A SR

  • Director
0 2016-05-05 0

BERTOLINO ARTHUR PETER EVP AND CHIEF MEDICAL OFFICER

  • Officer
34,001 2015-11-17 0

WAUGH JACOB CHIEF SCIENTIFIC OFFICER

  • Officer
28,413 2015-05-19 0

TUNNICLIFFE JONATHAN

  • Director
  • 10% Owner
0 2015-05-07 0

WOOTEN RONALD J

  • Director
  • 10% Owner
0 2015-05-07 0

NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.

NQ HCIF GENERAL PARTNER, L.P.

NQ HCIF GP, LTD.

  • 10% Owner
0 2015-05-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SJUTS DUSTIN S - Officer CHIEF COMMERCIAL OFFICER

2021-04-16 20:17:23 -0400 2021-04-15 F 411 $28.16 d 65,098 direct -1.6153 0.0 1 -1.6153 2

RANKIN AUBREY - Director - Officer PRESIDENT, INNOVATION & TECH aubrey and luanne rankin revocable living trust dated july 1, 2009

2021-04-06 19:41:39 -0400 2021-04-05 S 2 $28.28 d 411,325 indirect yes 1.8349 3.3761 3.3761 6 0.0 1

JOSHI ABHAY - Officer COO, PRESIDENT, R&D

2021-03-17 19:27:23 -0400 2021-03-15 F 1,354 $27.73 d 128,368 direct 5.3957 -1.9784 5.3957 2 -2.1583 5

MOXIE DWIGHT - Officer SVP, GC & SECRETARY

2021-03-17 19:29:27 -0400 2021-03-15 F 2,881 $27.73 d 49,479 direct 5.3957 -1.9784 5.3957 2 -2.1583 5

WARE OLIVIA C - Director

2021-03-10 19:13:48 -0500 2021-03-08 A 11,161 a 11,161 direct

WARE OLIVIA C - Director

2021-03-10 19:13:48 -0500 2021-03-08 A 6,408 a 6,408 direct 2.1715 2.3187 4.0486 5 0.0 1

RANKIN AUBREY - Director - Officer PRESIDENT, INNOVATION & TECH aubrey and luanne rankin revocable living trust dated july 1, 2009

2021-03-05 20:10:41 -0500 2021-03-04 S 33,119 $25.43 d 411,327 indirect yes 4.6608 15.3974 11.5273 21.9309 10 0.0 1

KOLAJA CAREY OCONNOR - Director

2021-03-02 20:17:34 -0500 2021-03-01 A 6,294 a 6,294 direct -0.3488 -0.7752 9.1473 13.5659 13 -6.8605 4

KOLAJA CAREY OCONNOR - Director

2021-03-02 20:17:34 -0500 2021-03-01 A 11,417 a 11,417 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
REVANCE THERAPEUTICS INC RVNC 2021-04-23 13:45:03 UTC -0.2291 0.2891 100000
REVANCE THERAPEUTICS INC RVNC 2021-04-23 13:15:03 UTC -0.2291 0.2891 95000
REVANCE THERAPEUTICS INC RVNC 2021-04-23 12:45:02 UTC -0.2291 0.2891 75000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 22:15:03 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 21:45:04 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 21:15:03 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 20:45:03 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 20:15:03 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 19:45:02 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 19:15:03 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 18:45:02 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 18:15:03 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 17:45:02 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 17:15:03 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 16:45:03 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 16:15:02 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 15:45:03 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 15:15:03 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 14:45:03 UTC -0.2291 0.2891 85000
REVANCE THERAPEUTICS INC RVNC 2021-04-22 14:15:03 UTC -0.2291 0.2891 85000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Trust for Professional Managers- Convergence Long/Short Equity Fund RVNC -921.0 shares, $-22232.94 2020-11-30 N-PORT
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund RVNC -26014.0 shares, $-627977.96 2020-11-30 N-PORT
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio RVNC -4452.0 shares, $-126169.68 2020-12-31 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund RVNC -31520.0 shares, $-893276.8 2020-12-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund RVNC -3.0 shares, $-44.4 2020-03-31 N-PORT
AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund RVNC -823.0 shares, $-10699.0 2019-09-30 N-PORT
FORUM FUNDS- ABSOLUTE CONVERTIBLE ARBITRAGE FUND RVNC -20600.0 shares, $-583804.0 2020-12-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund RVNC -13.0 shares, $-192.4 2020-03-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund RVNC -200.0 shares, $-5668.0 2020-12-31 N-PORT
VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND RVNC -52962.0 shares, $-1500943.08 2020-12-31 N-PORT
PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments RVNC -10949.0 shares, $-278542.56 2021-01-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- 361 Global Long/Short Equity Fund RVNC -103416.0 shares, $-2630903.04 2021-01-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund RVNC -12566.0 shares, $-319679.04 2021-01-31 N-PORT
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund RVNC -92000.0 shares, $-2340480.0 2021-01-31 N-PORT

Elevate your investments